Tirzepatide 60mg

Significant Weight Loss: Clinical trials (SURMOUNT program) showed that weekly injections (5 mg to 15 mg) resulted in a 15% to 21% reduction in body weight over 72 weeks.
Improved Glycemic Control: It is highly effective at lowering HbA1c and managing blood sugar levels, often outperforming other diabetes medications.
Appetite Regulation: By mimicking GIP and GLP-1 hormones, it slows gastric emptying, increases feelings of fullness, and reduces food cravings.
Cardiovascular and Metabolic Health: It has been shown to reduce systolic and diastolic blood pressure, improve lipid profiles, and reduce markers of inflammation.
Heart Failure Management: Trials indicate that it reduces the risk of worsening heart failure events or death from cardiovascular causes in patients with obesity.
Treatment of Obesity-Related Conditions: FDA approved for weight loss under the brand name Zepbound, it is also used for chronic weight management and treating obstructive sleep apnea (OSA).

Important: This product is sold strictly for research use only. It is not for human or animal consumption, and it is not intended for diagnostic, therapeutic, clinical, or veterinary use. By purchasing, you confirm that you are buying for lawful laboratory research purposes only.